As the prevalence of diabetes continues to climb, the number of individuals living with
diabetic complications will reach an unprecedented magnitude. The emergence of new …

Diabetic macular edema (DME) is the major cause of vision loss in diabetic persons.
Alteration of the blood–retinal barrier is the hallmark of this disease, characterized by …

Diabetes is considered a new pandemic of the modern world, and the number of sufferers is
steadily increasing. Sustained hyperglycemia promotes the production of free radicals and …

Context: Various drugs affect body weight as a side effect. Objective: We conducted this
systematic review and meta-analysis to summarize the evidence about commonly …

The association between hyperglycemia and inflammation and vascular complications in
diabetes is now well established. Antidiabetes drugs may alleviate inflammation by reducing …

Glucose‐dependent insulinotropic polypeptide (GIP) and glucagon‐like peptide‐1 (GLP‐1)
are the two primary incretin hormones secreted from the intestine on ingestion of various …

Aims Preliminary data from randomized trials with metabolic outcomes have shown that
treatment with dipeptidyl peptidase‐4 inhibitors (DPP4i) could be associated with a reduced …

Aim To conduct a meta‐analysis and systematic review to examine the effects of glucagon‐
like peptide‐1 receptor agonists (GLP‐1RAs) on clinical biomarkers of inflammation and …

Alzheimer's disease (AD) and Parkinson's disease (PD) are the most frequent
neurodegenerative disorders. Despite their pathophysiological and clinical differences, they …

Objective: Our objective was to determine whether exenatide exerts an antiinflammatory
effect. Research Design and Methods: Twenty-four patients were prospectively randomized …